BioLife Solutions, Inc. (BLFS) has a consensus analyst rating of Buy, based on 17 analysts covering the stock. Of those, 17 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for BLFS is $33.00, representing a +62.8% upside from the current price of $20.27. Price targets range from a low of $32.00 to a high of $34.00.
